Pharmacology
Summary
Benzodiazepines represent a class of psychoactive drugs predominantly utilized for their sedative-hypnotic properties. Their mechanism of action centers around binding to an allosteric site on the GABA-A receptor, amplifying its inhibitory effects on the central nervous system. Both short-acting ("-lam") and long-acting agents ("-pam") benzodiazepines exist, each displaying unique degrees of CNS depression. Key examples include diazepam, lorazepam, and oxazepam, as well as alprazolam, triazolam, and midazolam. They are metabolized by the liver, with long-acting agents forming active metabolites. Benzodiazepines are used to treat a variety of conditions, including in panic disorder, generalized anxiety disorder (SSRI/SNRI are 1st line), alcohol withdrawal, status epilepticus, and upper motor neuron disorders, and insomnia. They can also be used in general anesthesia and for conscious sedation.
Despite their various therapeutic roles, benzodiazepines are not without their pitfalls. Adverse effects include the emergence of tolerance, physical dependence, and withdrawal symptoms. Caution is advised when prescribing these agents to individuals with a history of substance use or those with liver conditions. Side effects such as somnolence, confusion, disorientation, and central ataxia are also associated with benzodiazepines, and are especially pronounced in the elderly. Flumazenil, a benzodiazepine receptor antagonist, can be used in case of overdose; however, it can precipitate seizures, especially in those with established benzodiazepine tolerance.
Lesson Outline
Don't stop here!
Get access to 133 more Pharmacology lessons & 13 more medical school learning courses with one subscription!
FAQs
Benzodiazepines exert their therapeutic effects by binding to a specific allosteric site on the GABA-A receptor, a chloride channel. This facilitates the action of GABA, which, in conjunction with glycine, serves as a primary inhibitory neurotransmitter in the CNS. By enhancing GABA's inhibitory effects, benzodiazepines increase the frequency of ion channel opening, leading to a decrease in neuronal excitability and manifesting as a calming or sedative effect.
Benzodiazepines, especially short-acting ones, carry a risk of addiction. Additionally, they can lead to side effects such as anterograde amnesia and central ataxia, the latter of which can result in falls, particularly in the elderly. Older individuals tend to be more susceptible to the side effects of benzodiazepines, which includes symptoms like somnolence, confusion, and disorientation. Co-administration of benzodiazepines with other CNS depressants, including alcohol, barbiturates, and 1st generation antihistamines, can heighten the risk of adverse effects.
The liver primarily metabolizes benzodiazepines, with many long-acting varieties forming active metabolites. Benzodiazepines bearing the "-pam" suffix, such as diazepam and lorazepam, are typically associated with longer durations of action and are often employed in the management of conditions like alcohol withdrawal. Conversely, those with the "-olam" suffix, such as triazolam, alprazolam, and midazolam, are known to be short-acting agents.
Flumazenil acts as a competitive antagonist at the benzodiazepine receptor. It is capable of reversing the sedative properties of benzodiazepines. However, its is known to precipitate seizures, especially in those with benzodiazepine tolerance or dependence.
Benzodiazepines are prescribed for a variety of conditions, such as anxiety and panic disorders, insomnia, parasomnias in children like sleepwalking and night terrors, and spasticity stemming from upper motor neuron disorders like MS, stroke, and spinal cord injuries. They are also pivotal in managing alcohol withdrawal and status epilepticus. Furthermore, due to their sedative and amnestic properties, benzodiazepines are routinely used in anesthesia, particularly for minor surgical procedures.
MCAT® is a registered trademark of the Association of American Medical Colleges. The United States Medical Licensing Examination (USMLE®) is a joint program of the Federation of State Medical Boards (FSMB®) and National Board of Medical Examiners (NBME®). NAPLEX® is a registered trademark of the National Association of Boards of Pharmacy. PANCE© is a registered trademark of the National Commission on Certification of Physician Assistants. NCLEX® is a registered trademark and service mark of the National Council of State Boards of Nursing, Inc. None of the trademark holders are endorsed by nor affiliated with Sketchy or this website.
